drugset / Trial / NCT02172287

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172287

Phase 3 Completed 623 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the long -term (six month) bronchodilator efficacy and safety of tiotropium inhalation capsules, salmeterol inhalation aerosol and placebo in patients with COPD. A secondary objective of this study was to compare the impact of tiotropium and salmeterol on humanistic and economic health outcomes, such as quality of life, patient preference and Health Resource Utilisation in this patient population.

Timeline

Start
1999-02
Primary completion
2000-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol Other / unclassified Inhaled
Subject Tiotropium Other / unclassified Inhaled